Literature DB >> 5381297

Choroideremia: a clinical and pathologic review.

C McCulloch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5381297      PMCID: PMC1310337     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  8 in total

1.  SEX-LINKED OCULAR DISORDERS: TRAIT EXPRESSIVITY IN MALES AND CARRIER FEMALES.

Authors:  G GOODMAN; H RIPPS; I M SIEGEL
Journal:  Arch Ophthalmol       Date:  1965-03

2.  Hereditary choroidoretinal degeneration. Study of a family including electroretinography and adaptometry.

Authors:  J H JACOBSON; G STEPHENS
Journal:  Arch Ophthalmol       Date:  1962-03

3.  The electroretinogram in choroideremia.

Authors:  G W BOUNDS; T L JOHNSTON
Journal:  Am J Ophthalmol       Date:  1955-02       Impact factor: 5.258

4.  Choroideremia; clinical and genetic aspects.

Authors:  A SORSBY; A FRANCESCHETTI; R JOSEPH; J B DAVEY
Journal:  Br J Ophthalmol       Date:  1952-10       Impact factor: 4.638

5.  Choroideremia. Visual defects in a heterozygote.

Authors:  G S Harris; J R Miller
Journal:  Arch Ophthalmol       Date:  1968-10

6.  Choroideremia. A pathological report.

Authors:  E V Rafuse; C McCulloch
Journal:  Can J Ophthalmol       Date:  1968-10       Impact factor: 1.882

7.  Choroideremia. Study of a family and literature review.

Authors:  M L Rubin; R S Fishman; R A McKay
Journal:  Arch Ophthalmol       Date:  1966-10

8.  Studies on the fine structure and the rhodopsin cycle of the rabbit retina in experimental degeneration induced by sodium iodate.

Authors:  A Grignolo; N Orzalesi; G A Calabria
Journal:  Exp Eye Res       Date:  1966-01       Impact factor: 3.467

  8 in total
  9 in total

1.  Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Ilaria Passerini; Simona Palchetti; Andrea Sodi; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-27       Impact factor: 3.117

2.  Differential diagnosis between the primary total choroidal vascular atrophies.

Authors:  K Takki
Journal:  Br J Ophthalmol       Date:  1974-01       Impact factor: 4.638

3.  Stargardt's hereditary progressive macular degeneration.

Authors:  A R Irvine; F L Wergeland
Journal:  Br J Ophthalmol       Date:  1972-11       Impact factor: 4.638

4.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

5.  Deep Scleral Exposure: A Degenerative Outcome of End-Stage Stargardt Disease.

Authors:  Winston Lee; Jana Zernant; Takayuki Nagasaki; Stephen H Tsang; Rando Allikmets
Journal:  Am J Ophthalmol       Date:  2018-07-26       Impact factor: 5.258

6.  Choroideremia-locus maps between DXS3 and DXS11 on Xq.

Authors:  A Gal; F Brunsmann; D Hogenkamp; K Rüther; D Ahlert; T F Wienker; W Hammerstein; I H Pawlowitzki
Journal:  Hum Genet       Date:  1986-06       Impact factor: 4.132

7.  OCT angiography for the diagnosis and management of choroidal neovascularization secondary to choroideremia.

Authors:  Ratnesh Ranjan; Shishir Verghese; Romit Salian; George J Manayath; Veerappan R Saravanan; Venkatapathy Narendran
Journal:  Am J Ophthalmol Case Rep       Date:  2021-02-25

Review 8.  Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies.

Authors:  Alessandro Abbouda; Filippo Avogaro; Mariya Moosajee; Enzo Maria Vingolo
Journal:  Medicina (Kaunas)       Date:  2021-01-12       Impact factor: 2.430

9.  Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab.

Authors:  Neal V Palejwala; Andreas K Lauer; Richard G Weleber
Journal:  Clin Ophthalmol       Date:  2014-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.